Octreotide Acetate is a hypothalamic pituitary hormone and related drug - auxin release inhibiting hormone analog developed by Novartis. Its main component is octreotide, and its chemical formula is C49H66N10O10S2. Mainly suitable for acromegaly requiring long-term medication, as well as some gastrointestinal carcinoids and neuroendocrine tumors. We has reserved the technical package for this project, which can quickly develop and transfer technology for customers.
CAS: 83150-76-9/79517-01-4
Molecular formula: C50H68N10O10S2
Average molecular weight: 1033.27
Precise molecular weight: 1032.46
Isoelectric point (PI) :9.93
Product application:
Its effect is similar to that of natural endogenous somatostatin, with a strong and lasting effect. It is used to relieve symptoms caused by tumors of the gastric, intestinal, and pancreatic endocrine systems or carcinoid tumors. DSPE-PEG-Octreotide is a lipid nanoparticle material.
For many years, the original intention remains unchanged, just to do one thing well, the company always believes that professional first can cast the value of the brand. You are worthy of trust
133 3604 2711
Record number：